KR20070060208A - Corynebacterium microorganisms having excellent 5'-inosine acid productivity with increased fumarase gene expression and a method for producing 5'-inosine acid using the same - Google Patents
Corynebacterium microorganisms having excellent 5'-inosine acid productivity with increased fumarase gene expression and a method for producing 5'-inosine acid using the same Download PDFInfo
- Publication number
- KR20070060208A KR20070060208A KR1020050119250A KR20050119250A KR20070060208A KR 20070060208 A KR20070060208 A KR 20070060208A KR 1020050119250 A KR1020050119250 A KR 1020050119250A KR 20050119250 A KR20050119250 A KR 20050119250A KR 20070060208 A KR20070060208 A KR 20070060208A
- Authority
- KR
- South Korea
- Prior art keywords
- microorganism
- corynebacterium
- kccm
- producing
- inosinic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 244000005700 microbiome Species 0.000 title claims abstract description 39
- 108010036781 Fumarate Hydratase Proteins 0.000 title claims abstract description 36
- 102100036160 Fumarate hydratase, mitochondrial Human genes 0.000 title claims abstract description 29
- 241000186216 Corynebacterium Species 0.000 title claims abstract description 20
- 230000014509 gene expression Effects 0.000 title claims abstract description 19
- 238000004519 manufacturing process Methods 0.000 title claims description 11
- 239000002253 acid Substances 0.000 title description 4
- 229960003786 inosine Drugs 0.000 title description 4
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 53
- GRSZFWQUAKGDAV-KQYNXXCUSA-N IMP Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(NC=NC2=O)=C2N=C1 GRSZFWQUAKGDAV-KQYNXXCUSA-N 0.000 claims abstract description 38
- GRSZFWQUAKGDAV-UHFFFAOYSA-N Inosinic acid Natural products OC1C(O)C(COP(O)(O)=O)OC1N1C(NC=NC2=O)=C2N=C1 GRSZFWQUAKGDAV-UHFFFAOYSA-N 0.000 claims abstract description 38
- 235000013902 inosinic acid Nutrition 0.000 claims abstract description 38
- 230000000694 effects Effects 0.000 claims abstract description 20
- 238000000034 method Methods 0.000 claims abstract description 20
- 241000186145 Corynebacterium ammoniagenes Species 0.000 claims description 47
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 16
- 239000013598 vector Substances 0.000 claims description 14
- 229910021529 ammonia Inorganic materials 0.000 claims description 8
- 241000894007 species Species 0.000 claims description 4
- 230000001131 transforming effect Effects 0.000 claims description 3
- 238000012258 culturing Methods 0.000 claims description 2
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 18
- 239000002609 medium Substances 0.000 description 18
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
- 235000018102 proteins Nutrition 0.000 description 12
- 102000004169 proteins and genes Human genes 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 11
- 238000000855 fermentation Methods 0.000 description 10
- 239000000499 gel Substances 0.000 description 10
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 230000010261 cell growth Effects 0.000 description 9
- 230000004151 fermentation Effects 0.000 description 9
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 8
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 8
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 8
- 229930024421 Adenine Natural products 0.000 description 7
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 7
- 229960000643 adenine Drugs 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 6
- 108020004414 DNA Proteins 0.000 description 5
- 239000001888 Peptone Substances 0.000 description 5
- 108010080698 Peptones Proteins 0.000 description 5
- 108010026552 Proteome Proteins 0.000 description 5
- 229940041514 candida albicans extract Drugs 0.000 description 5
- 235000019319 peptone Nutrition 0.000 description 5
- 108090000765 processed proteins & peptides Proteins 0.000 description 5
- 239000012138 yeast extract Substances 0.000 description 5
- 239000004201 L-cysteine Substances 0.000 description 4
- 235000013878 L-cysteine Nutrition 0.000 description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 229960002685 biotin Drugs 0.000 description 4
- 235000020958 biotin Nutrition 0.000 description 4
- 239000011616 biotin Substances 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 229910000358 iron sulfate Inorganic materials 0.000 description 4
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 4
- 235000019341 magnesium sulphate Nutrition 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 4
- 229910000368 zinc sulfate Inorganic materials 0.000 description 4
- 229960001763 zinc sulfate Drugs 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 3
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 3
- 241000186031 Corynebacteriaceae Species 0.000 description 3
- 230000004544 DNA amplification Effects 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 229930091371 Fructose Natural products 0.000 description 3
- 239000005715 Fructose Substances 0.000 description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 3
- 239000001099 ammonium carbonate Substances 0.000 description 3
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 3
- 239000001110 calcium chloride Substances 0.000 description 3
- 229910001628 calcium chloride Inorganic materials 0.000 description 3
- 239000013611 chromosomal DNA Substances 0.000 description 3
- 238000001360 collision-induced dissociation Methods 0.000 description 3
- 238000012136 culture method Methods 0.000 description 3
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 235000013923 monosodium glutamate Nutrition 0.000 description 3
- 229940073490 sodium glutamate Drugs 0.000 description 3
- MSTNYGQPCMXVAQ-RYUDHWBXSA-N (6S)-5,6,7,8-tetrahydrofolic acid Chemical compound C([C@H]1CNC=2N=C(NC(=O)C=2N1)N)NC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 MSTNYGQPCMXVAQ-RYUDHWBXSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 108020004638 Circular DNA Proteins 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- 102000003960 Ligases Human genes 0.000 description 2
- 108090000364 Ligases Proteins 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 229910000365 copper sulfate Inorganic materials 0.000 description 2
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 2
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 2
- 235000019797 dipotassium phosphate Nutrition 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 235000013882 gravy Nutrition 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
- 229930027917 kanamycin Natural products 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 229960000318 kanamycin Drugs 0.000 description 2
- 229930182823 kanamycin A Natural products 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229940099596 manganese sulfate Drugs 0.000 description 2
- 239000011702 manganese sulphate Substances 0.000 description 2
- 235000007079 manganese sulphate Nutrition 0.000 description 2
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000013028 medium composition Substances 0.000 description 2
- 235000013379 molasses Nutrition 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 229910000160 potassium phosphate Inorganic materials 0.000 description 2
- 235000011009 potassium phosphates Nutrition 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 238000011218 seed culture Methods 0.000 description 2
- 239000013605 shuttle vector Substances 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 2
- 235000019345 sodium thiosulphate Nutrition 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000005460 tetrahydrofolate Substances 0.000 description 2
- 229960000344 thiamine hydrochloride Drugs 0.000 description 2
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 2
- 239000011747 thiamine hydrochloride Substances 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 229940086388 thiamine hydrochloride 5 mg Drugs 0.000 description 2
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- UMCMPZBLKLEWAF-BCTGSCMUSA-N 3-[(3-cholamidopropyl)dimethylammonio]propane-1-sulfonate Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCC[N+](C)(C)CCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 UMCMPZBLKLEWAF-BCTGSCMUSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 238000009631 Broth culture Methods 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- 229910021380 Manganese Chloride Inorganic materials 0.000 description 1
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 238000010847 SEQUEST Methods 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 150000001413 amino acids Chemical group 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 229940088129 calcium pantothenate 10 mg Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 239000007376 cm-medium Substances 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- WHHGLZMJPXIBIX-UHFFFAOYSA-N decabromodiphenyl ether Chemical compound BrC1=C(Br)C(Br)=C(Br)C(Br)=C1OC1=C(Br)C(Br)=C(Br)C(Br)=C1Br WHHGLZMJPXIBIX-UHFFFAOYSA-N 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000005040 ion trap Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000001155 isoelectric focusing Methods 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 239000011565 manganese chloride Substances 0.000 description 1
- 235000002867 manganese chloride Nutrition 0.000 description 1
- 229940099607 manganese chloride Drugs 0.000 description 1
- KNLQKHUBPCXPQD-UHFFFAOYSA-N manganese;sulfuric acid Chemical compound [Mn].OS(O)(=O)=O KNLQKHUBPCXPQD-UHFFFAOYSA-N 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 108091027963 non-coding RNA Proteins 0.000 description 1
- 102000042567 non-coding RNA Human genes 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- -1 potassium ferricyanide Chemical compound 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000019525 primary metabolic process Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 230000002463 transducing effect Effects 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 238000000539 two dimensional gel electrophoresis Methods 0.000 description 1
- 238000009834 vaporization Methods 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/77—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/30—Nucleotides
- C12P19/32—Nucleotides having a condensed ring system containing a six-membered ring having two N-atoms in the same ring, e.g. purine nucleotides, nicotineamide-adenine dinucleotide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
본 발명은 5'-이노신산을 생산하는 코리넥박테리움 속 미생물로서, 모균주의 푸마레이즈 활성을 코딩하는 유전자의 발현량에 비하여 푸마레이즈 활성을 코딩하는 유전자의 발현량이 증가된 미생물 및 그를 이용하여 5'-이노신산을 생산하는 방법을 제공한다. The present invention relates to a microorganism belonging to the genus Corynebacterium producing 5'-inosinic acid, the microorganism of which the expression amount of the gene encoding the fumarase activity is increased compared to the expression amount of the gene encoding the fumarase activity of the parent strain. Provided are methods for producing 5'-inosinic acid.
Description
도 1은 프로테옴 분석에 의하여 코리네박테리움 암모니아게네스 야생주 (ATCC 6872)와 코리네박테리움 암모니아게네스 CJHB100 (KCCM-10330)의 푸마레이즈의 발현 분석 결과를 나타내는 도면이다. 1 is a graph showing the results of the analysis of the fumarase expression of Corynebacterium ammonia genes wild strain (ATCC 6872) and Corynebacterium ammonia genes CJHB100 (KCCM-10330) by proteome analysis.
도 2는 코리네박테리움 암모니아게네스 야생주 (ATCC 6872) 유래의 푸마레이즈 유전자를 클로닝하는 과정을 나타내는 도면이다. 2 is a diagram illustrating a process of cloning the fumarase gene from Corynebacterium ammonia genes wild strain (ATCC 6872).
본 발명은 세포 성장이 우수하고 5'-이노신산 생산성이 우수한 코리네박테리움 속 미생물 및 그를 이용하여 5'-이노신산을 생산하는 방법에 관한 것이다.The present invention relates to a microorganism of the genus Corynebacterium having excellent cell growth and excellent productivity of 5'-inosinic acid, and a method for producing 5'-inosine acid using the same.
5'-이노신산은 핵산 생합성 대사계의 중간물질로 동식물의 체내에서 생리적으로 중요한 의미를 갖는다. 또한, 5'-이노신산은 식품, 의약품, 및 각종 의료적 용도로 다양한 분야에서 이용되고 있다. 특히, 5'-이노신산은 글루타민산 나트륨과 함께 사용되는 경우 맛의 상승효과가 우수하여, 핵산계 조미료로서 사용되고 있다. 5'-inosinic acid is an intermediate in the nucleic acid biosynthetic metabolic system and has a physiologically significant meaning in the body of animals and plants. In addition, 5'-inosinic acid is used in various fields for food, medicine, and various medical uses. In particular, 5'-inosinic acid is used as a nucleic acid-based seasoning because of its excellent synergistic effect when used with sodium glutamate.
종래 5'-이노신산의 생산 방법으로서, 직접발효법이 알려져 있었다. 예를 들면, 한국특허출원 공개 제10-2003-0042972호에는 발린, 루신, 이소루신의 유사체, 및 테트라히드로폴레이트의 유사체에 대한 내성을 갖고, 5'-이노신산을 생산하는 코리네박테리움 암모니아게네스 CJHB100 (수탁번호 KCCM-10330) 균주 및 그를 이용하여 5'-이노신산을 생산하는 방법이 개시되어 있다. As a method for producing 5'-inosinic acid, a direct fermentation method has been known. For example, Korean Patent Application Publication No. 10-2003-0042972 discloses corynebacterium ammonia that is resistant to valine, leucine, analogs of isoleucine, and analogs of tetrahydrofolate, and produces 5'-inosinic acid. A Gennes CJHB100 (Accession No. KCCM-10330) strain and a method for producing 5'-inosine acid using the same are disclosed.
그러나, 코리네박테리움 암모니아게네스 CJHB100 (수탁번호 KCCM-10330) 균주는 모균주로 사용된 코리네박테리움 암모니아게네스 CJIP009 (수탁번호 KCCM-10226) 균주에 비하여 5'-이노신산의 생산성은 우수하나, 세포 성장 속도가 느리다는 단점이 있었다. However, Corynebacterium ammonia genes CJHB100 (Accession No. KCCM-10330) strains were superior to the Corynebacterium ammonia genes CJIP009 (Accession No. KCCM-10226) strains used as parent strains. However, there was a disadvantage that the cell growth rate is slow.
따라서, 상기한 종래 기술에 의하더라도 여전히 생산성이 개선된 5'-이노신산 생산 균주를 개발할 필요성이 요구되고 있었다. Therefore, there is a need for developing a 5'-inosinic acid-producing strain which is still improved in productivity according to the above-described prior art.
이에 본 발명자들은 코리네박테리움 암모니아게네스 CJHB100 (수탁번호 KCCM-10330) 균주의 5'-이노신산의 생산성을 개량하고자 노력하던 중, 코리네박테리움 암모니아게네스의 야생주 (수탁번호 ATCC6872)와 코리네박테리움 암모니아게네스 CJHB100 (수탁번호 KCCM-10330) 균주의 프로테옴 분석을 통하여 상기 야생주에서 푸마레이즈가 과발현되고 있다는 것을 발견하고, 상기 푸마레이즈를 코딩하는 유전자를 코리네박테리움 암모니아게네스 CJHB100 (수탁번호 KCCM-10330) 균주에 형질도입함으로써 본 발명을 완성하기에 아르렀다. Therefore, the present inventors are trying to improve the productivity of 5'-inosinic acid of Corynebacterium ammonia genes CJHB100 (Accession No. KCCM-10330) strain, while the wild strain of Corynebacterium ammonia genes (Accession No. ATCC6872) The proteome analysis of the Corynebacterium ammonia genes CJHB100 (Accession No. KCCM-10330) strain found that the fumarase was overexpressed in the wild state, and the gene encoding the fumarase was corynebacterium ammonia genes. The present invention was accomplished by transducing the CJHB100 (Accession No. KCCM-10330) strain.
본 발명의 목적은 5'-이노신산의 생산성이 향상된 코리네박테리움 속 미생물을 제공하는 것이다. An object of the present invention is to provide a microorganism of the genus Corynebacterium with improved productivity of 5'-inosinic acid.
본 발명의 또다른 목적은 상기 미생물을 이용하여 5'-이노신산을 생산하는 방법을 제공하는 것이다. Another object of the present invention is to provide a method for producing 5'-inosinic acid using the microorganism.
본 발명은 5'-이노신산을 생산하는 코리넥박테리움 속 미생물로서, 모균주의 푸마레이즈 활성을 코딩하는 유전자의 발현량에 비하여 푸마레이즈 활성을 코딩하는 유전자의 발현량이 증가된 미생물을 제공한다.The present invention provides a microorganism of the genus Corynebacterium producing 5'-inosinic acid, the expression amount of the gene encoding the fumarase activity compared to the expression amount of the gene encoding the fumarase activity of the parent strain.
본 발명의 일 구체예는, 본 발명의 미생물에 있어서 상기 푸마레이즈 활성을 코딩하는 유전자는 세포 외부로부터 추가적으로 도입된 것이거나, 내재적 푸마레이즈 활성을 코딩하는 유전자가 증폭된 것인 미생물이다.In one embodiment of the present invention, in the microorganism of the present invention, the gene encoding the fumarase activity is a microorganism in which the gene encoding the intrinsic fumarase activity is additionally introduced or amplified.
본 발명에 있어서, 상기 모균주는 5'-이노신산을 생산하는 코리네박테리움 속 미생물이면 어느 것이나 포함된다. 바람직하게는, 5'-이노신산을 생산하는 코리네박테리움 암모니아게네스 종의 미생물이다. In the present invention, the parent strain includes any microorganism of the genus Corynebacterium producing 5'-inosinic acid. Preferably, it is a microorganism of Corynebacterium ammonia gene species that produces 5'-inosinic acid.
본 발명의 일 구체예는, 본 발명의 미생물에 있어서 상기 모균주는 코리네박테리움 암모니아게네스 ATCC6872, 코리네박테리움 암모니아게네스 CJIP009 (KCCM-10226), 코리네박테리움 암모니아게네스 CJHK25 (KCCM-10520) 및 코리네박테리움 암모니아게네스 CJHB100 (KCCM-10330)로 이루어진 군으로부터 선택된 하나 이상의 균주인 미생물이다.In one embodiment of the present invention, the parent strain in the microorganism of the present invention Corynebacterium ammonia genes ATCC6872, Corynebacterium ammonia genes CJIP009 (KCCM-10226), Corynebacterium ammonia genes CJHK25 ( KCCM-10520) and Corynebacterium ammonia genes CJHB100 (KCCM-10330).
본 발명의 일 구체예는, 본 발명의 미생물에 있어서 코리네박테리움 암모니아게네스 CJHB100 (수탁번호 KCCM-10330)에 푸마레이즈 활성을 코딩하는 유전자가 도입된 코리네박테리움 암모니아게네스 CJHB100 (수탁번호 KCCM-10330)의 변이 미생물이다. 본 구체예에서 유전자가 도입되는 모균주인 코리네박테리움 암모니아게네스 CJHB100 (수탁번호 KCCM-10330) 는, 발린, 루신 및 이소루신의 유사체, 및 테트라히드로폴레이트의 유사체에 대한 내성을 갖고, 종래의 알려진 미생물보다 5'-이노신산을 고농도 및 고수율로 생산할 수 있는 세포이다. 상기 코리네박테리움 암모니아게네스 CJHB100 (수탁번호 KCCM-10330) 균주는 한국특허 공개 제10-2003-0042972호에 개시되어 있으며, 기술의 편의를 위하여 그 전체 내용은 본 명세서에 원용에 의하여 포함되어진다. 바람직하게는, 상기 변이 미생물은 코리네박테리움 암모니아게네스 (Corynebacterium ammoniagenes) CJFUM101 (수탁번호 KCCM-10689P)인 미생물이다.One embodiment of the present invention, Corynebacterium ammonia genes CJHB100 (Accession No. KCCM-10330) in the microorganism of the present invention Corynebacterium ammonia genes CJHB100 (Accession Mutation of number KCCM-10330) is a microorganism. Corynebacterium ammonia genes CJHB100 (Accession No. KCCM-10330), the parent strain into which genes are introduced in this embodiment, has resistance to analogs of valine, leucine and isoleucine, and analogs of tetrahydrofolate, Cells capable of producing higher concentrations and higher yields of 5'-inosinic acid than conventionally known microorganisms. The Corynebacterium ammonia genes CJHB100 (Accession No. KCCM-10330) strain is disclosed in Korean Patent Publication No. 10-2003-0042972, the entire contents of which are incorporated herein by reference for convenience of technology. Lose. Preferably, the variant microorganism is a microorganism having Corynebacterium ammoniagenes CJFUM101 (Accession Number KCCM-10689P).
본 발명의 균주에 있어서, 모균주에 비하여 푸마레이즈 활성을 코딩하는 유전자의 발현량이 증가됨으로써, 모균주의 성장이 느린 단점을 보완함으로써, 5'-이노신산의 생산성을 높이는 것으로 여겨지나, 본 발명이 특정한 이론에 한정되는 것은 아니다. In the strain of the present invention, the expression amount of the gene encoding the fumarase activity is increased compared to the parent strain, thereby compensating for the disadvantage of slow growth of the parent strain, and it is believed that the productivity of 5'-inosinic acid is increased. It is not limited to a specific theory.
본 발명의 미생물에 있어서, "푸마레이즈 활성"이란 푸마레이트를 말레이트로 가역적으로 전환시키는 활성을 가진 효소를 의미한다. 이러한 활성을 갖는 효소이면, 그 기원과 관계없이 본 발명에 사용될 수 있다. 바람직하게는, 코리네박테리움 암모니아게네스 (Corynebacterium ammoniagenes)로부터 유래된 것이다. In the microorganism of the present invention, "fumarase activity" means an enzyme having an activity for reversibly converting fumarate to malate. Any enzyme having such activity can be used in the present invention regardless of its origin. Preferably, it is derived from Corynebacterium ammoniagenes.
본 발명의 미생물은 외래의 푸마레이즈 활성을 코딩하는 유전자를 코리네박테리움 속 미생물 (예를 들면, 코리네박테리움 암모니아게네스 CJHB100 (수탁번호 KCCM-10330))에 도입함으로써 제조될 수 있다. 외래 유전자를 모균주에 도입하는 과정은 당업계에 잘 알려져 있는 임의의 방법이 사용될 수 있다. 예를 들면, 상기 유전자 또는 유전자를 포함하는 벡터를 형질전환, 트란스펙션 및 전기천공법과 같은 유전자 도입 방법을 사용하여 모균주에 도입시킴으로써 제작될 수 있으나, 이들 예에 한정되는 것은 아니다. The microorganism of the present invention can be prepared by introducing a gene encoding foreign fumarase activity into a microorganism of the genus Corynebacterium (for example, Corynebacterium ammonia genes CJHB100 (Accession No. KCCM-10330)). The process of introducing the foreign gene into the parent strain can be used by any method well known in the art. For example, the gene or the vector containing the gene may be produced by introducing into the parent strain using a gene introduction method such as transformation, transfection and electroporation, but is not limited to these examples.
본 발명에 있어서, "푸마레이즈 활성을 코딩하는 유전자의 발현량이 증가된"이란, 모균주의 내재적 푸마레이즈 활성을 코딩하는 유전자의 발현량보다 증가된 유전자 발현량을 갖는다는 것을 의도한 것이다. 따라서, 모균주 또는 모균주와 다른 미생물의 상기 유전자를 증폭하고 얻어진 증폭된 상기 유전자 또는 상기 유전자를 포함하는 벡터를 상기 모균주에 도입시켜 얻어지는 코리네박테리움 속 미생물 (예를 들면, 코리네박테리움 암모니아게네스) 뿐만 아니라, 모균주의 상기 유전자를 유전자 증폭 기법에 의하여 증폭함으로써, 상기 유전자의 세포 내 발현량이 내재적 발현량 보다 증가된 상기 모균주도 본 발명의 균주에 포함되는 것이다. In the present invention, "the increased expression amount of the gene encoding fumarase activity" is intended to have an increased gene expression amount than the expression amount of the gene encoding the intrinsic fumarase activity of the parent strain. Thus, a microorganism of the genus Corynebacterium obtained by amplifying the gene of the parent strain or the microorganism and other microorganisms and introducing the amplified gene or vector containing the gene into the parent strain (for example, Corynebacte In addition to the ammonia gene), the parent strain of which the expression level of the gene of the mother strain is increased by an amplification technique by the gene amplification technique is also included in the strain of the present invention.
본 발명은 또한, 본 발명의 균주를 배양하는 단계를 포함하는, 5'-이노신산을 생산하는 방법을 제공한다. 본 발명의 균주의 배양에 사용되는 배지 및 기타 배양 조건은 통상의 코리네박테리움 속 미생물의 배양에 사용되는 배지이면 어느 것이나 사용될 수 있다. 또한, 배양 방법도 당업계에 알려진 임의의 배양 방법, 예를 들면, 회분식, 연속식 및 유가식 배양 방법 등이 사용될 수 있으나, 이들 예에 한 정되는 것은 아니다. The present invention also provides a method of producing 5'-inosinic acid, comprising culturing the strain of the present invention. The medium and other culture conditions used for the culture of the strain of the present invention can be used as long as the medium used for the culture of microorganism of the genus Corynebacterium. In addition, the culture method may be used any culture method known in the art, for example, batch, continuous and fed-batch culture method, but is not limited to these examples.
본 발명의 방법에 있어서, 배양물에 생산된 5'-이노신산은 당업계에 알려진 임의의 방법에 의하여 추가적으로 정제될 수 있다. In the method of the present invention, the 5'-inosinic acid produced in the culture can be further purified by any method known in the art.
본 발명은 또한 푸마레이즈 활성을 코딩하는 유전자를 포함하는 벡터를 5'-이노신산을 생산하는 코리넥박테리움 속 미생물에 형질전환시키는 단계를 포함하는, 상기한 바와 같은 본 발명에 따른 미생물을 제조하는 방법을 제공한다. The present invention also provides a method for producing a microorganism according to the present invention, comprising transforming a vector comprising a gene encoding fumarase activity to a microorganism of the genus Corynebacterium producing 5'-inosinic acid. Provide a method.
본 발명에 따른 미생물을 제조하는 방법에 있어서, 상기 벡터란 유전자를 숙주 세포에 운반하는 운반체로서, "플라스미드", "벡터" 및 "카세트"가 포함될 수 있다. 상기 벡터는 세포의 중심 대사의 일부분이 아닌 유전자를 종종 가지고 있으며, 보통 2중가닥 원형 DNA 단편이 염색체 외 요소를 말한다. 본 명세서에서 "플라스미드", "벡터" 및 "카세트"는 상호 교환가능하게 사용된다. 상기 요소는 많은 뉴클레오티드 서열이 연결되거나 재조합되어진 독특한 구조체 (unique construction)로서 프로모터 및 적합한 3′비번역 서열과 함께 선택된 유전자 산물을 코딩하는 DNA를 세포에 도입시킬 수 있는, 임의의 원천으로부터 유래된 독립적으로 복제하는 서열, 게놈 삽입 서열, 파지 또는 뉴클레오티드 서열, 선형 또는 원형, 단일 또는 2중가닥의 DNA 또는 RNA일 수 있다. 바람직하게는, 상기 벡터는 도 2에 나타낸 바와 같은 p117-FUM 벡터이다.In the method for producing a microorganism according to the present invention, the vector is a carrier for delivering a gene to a host cell, and may include "plasmid", "vector" and "cassette". The vectors often carry genes that are not part of the cell's central metabolism, usually double stranded circular DNA fragments refer to extrachromosomal elements. As used herein, "plasmid", "vector" and "cassette" are used interchangeably. The element is an independent construction derived from any source capable of introducing into the cell DNA encoding a selected gene product with a promoter and a suitable 3 ′ untranslated sequence as a unique construction in which many nucleotide sequences are linked or recombined. Sequences, genomic insertion sequences, phage or nucleotide sequences, linear or circular, single or double stranded DNA or RNA. Preferably, the vector is a p117-FUM vector as shown in FIG.
이하 본 발명의 일 균주인 코리네박테리움 암모니아게네스 CJFUM101 (KCCM-10689P)의 제작 과정을 통하여 본 발명을 보다 상세하게 설명한다.Hereinafter, the present invention will be described in more detail through the preparation process of Corynebacterium ammonia genes CJFUM101 (KCCM-10689P).
본 발명의 코리네박테리움 암모니아게네스 CJFUM101 (KCCM-10689P) 균주는 코리네박테리움 암모니아게네스 CJHB100 (KCCM-10330)를 푸마레이즈 활성을 코딩하는 유전자로 형질전환하여 얻어진 재조합 균주이다. 먼저, 숙주로 사용된 코리네박테리움 암모니아게네스 CJHB100 (KCCM-10330)와 야생주 (ATCC 6872)의 생체 내 단백질들의 분포와 상태를 총괄적으로 측정하여 코리네박테리움 암모니아게네스 야생주 (ATCC 6872)에서 과발현되는 단백질들을 선별하였다. 선별된 단백질들 중 하나가 푸마레이즈로 동정되었다. 도 1은 프로테옴 분석에 의하여 코리네박테리움 암모니아게네스 야생주 (ATCC 6872)와 코리네박테리움 암모니아게네스 CJHB100 (KCCM-10330)의 푸마레이즈의 발현 분석 결과를 나타내는 도면이다. Corynebacterium ammonia genes CJFUM101 (KCCM-10689P) strain of the present invention is a recombinant strain obtained by transforming Corynebacterium ammonia genes CJHB100 (KCCM-10330) with a gene encoding fumarase activity. First, the distribution and status of proteins in vivo in Corynebacterium ammonia genes CJHB100 (KCCM-10330) and wild strain (ATCC 6872) used as hosts were measured collectively to determine the corynebacterium ammonia genes wild strain (ATCC). Proteins overexpressed in 6872) were selected. One of the selected proteins was identified as fumarase. 1 is a graph showing the results of the analysis of the fumarase expression of Corynebacterium ammonia genes wild strain (ATCC 6872) and Corynebacterium ammonia genes CJHB100 (KCCM-10330) by proteome analysis.
이렇게 선별된 과발현 단백질의 유전정보를 염색체 서열정보를 바탕으로 분석하여 단백질 유전자를 PCR로 증폭하였다. 이렇게 증폭된 염색체 DNA를 제한효소 BamHI과 EcoRV을 이용하여 절단하였다. 이렇게 얻은 염색체 DNA 단편을 전기영동한 후 회수하여 사용하였다. 이렇게 제작된, 푸마레이즈 유전자를 BamHI과 EcoRV로 절단된 대장균과 코리네형 세균에서 발현 가능한 셔틀벡터인 pECCG117 (KFCC-10673/KFCC-10674)에 삽입하고, T4 리가제를 이용하여 결찰 반응을 수행하고, 얻어진 벡터를 코리네박테리움 암모니아게네스 CJHB100 (KCCM-10330)에 형질전환하였다. 도 2는 코리네박테리움 암모니아게네스 야생주 (ATCC 6872) 유래의 푸마레이즈 유전자를 클로닝하는 과정을 나타내는 도면이다. The genetic information of the selected overexpression protein was analyzed based on the chromosomal sequence information and the protein gene was amplified by PCR. The amplified chromosomal DNA was digested using restriction enzymes Bam HI and Eco RV. The chromosomal DNA fragments thus obtained were electrophoresed and recovered. The fumarase gene thus produced was inserted into pECCG117 (KFCC-10673 / KFCC-10674), a shuttle vector expressing E. coli and coryneform bacteria, which were cleaved with Bam HI and Eco RV, and subjected to ligation using T4 ligase. The obtained vector was transformed into Corynebacterium ammonia genes CJHB100 (KCCM-10330). 2 is a diagram illustrating a process of cloning the fumarase gene from Corynebacterium ammonia genes wild strain (ATCC 6872).
얻어진 균주를 카나마이신이 포함된 CM 한천 배지 (펩톤 1%, 육즙 1%, 염화나트륨 0.25%, 효모 추출물 1%, 아데닌 100 mg/ml, 구아닌 100 mg/ml, 한천 2% (pH 7.2))에 도말하여 성장하는 균주를 선별하였다. 선별된 균주를 코리네박테리움 암 모니아게네스 CJFUM101로 명명하였으며, 이를 부다페스트 조약하의 국제기탁기관인 서울 서대문구 홍제 1동 소재의 한국미생물보존센터 (Korean Culture Center of Microorganisms, KCCM)에 2005년 11월 2일자로 수탁번호 KCCM-10689P호로 기탁하였다.Stain the resulting strain on CM agar medium containing kanamycin (1% peptone, 1% gravy, 0.25% sodium chloride, 1% yeast extract, 100 mg / ml adenine, 100 mg / ml guanine, 2% pH 7.2) Growing strains were selected. The selected strain was named Corynebacterium ammoniagenes CJFUM101, and it was assigned to the Korean Culture Center of Microorganisms (KCCM) in Hongje 1-dong, Seodaemun-gu, Seoul under the Treaty of Budapest. Deposited with accession number KCCM-10689P as date.
본 발명의 균주의 배양에 사용될 수 있는 영양 배지, 최소 배지, 종 배지, 플라스크 발효 배지, 발효조 종 배지 및 발효조 본 배지는, 표 1에서 나타낸 바와 같은 조성으로 이루어진 배지일 수 있다. 그러나, 배지 조성은 표 1에 나타낸 배지에 제한되지는 않으며, 코리네박테리움 암모니아게네스의 배양에 적합한 모든 배양 배지를 사용할 수 있다.Nutritional medium, minimal medium, species medium, flask fermentation medium, fermenter seed medium and fermenter which can be used in the cultivation of the strain of the present invention The medium may be a medium having a composition as shown in Table 1. However, the medium composition is not limited to the medium shown in Table 1, and any culture medium suitable for the culture of Corynebacterium ammonia genes can be used.
표 1. 본 발명에서 사용된 배지 조성Table 1. Medium composition used in the present invention
이하 본 발명을 실시예를 통하여 보다 상세하게 설명한다. 그러나, 이들 실시예는 본 발명을 예시적으로 설명하기 위한 것으로 본 발명의 범위가 이들 실시예에 한정되는 것은 아니다. Hereinafter, the present invention will be described in more detail with reference to Examples. However, these examples are for illustrative purposes only and the scope of the present invention is not limited to these examples.
실시예Example
실시예Example 1: 프로테옴 분석을 통한 과발현 단백질로서 1: As an overexpressed protein through proteome analysis 푸마레이즈의Fumarize 선정 selection
본 실시예에서는, 프로테오믹스 기법을 이용하여 코리네형 세균의 유전자 발현을 분석하였다. 코리네박테리움 암모니아게네스 야생주 (ATCC 6872)와 CJHB100 (KCCM-10330)를 원당 가수분해물 (포도당 50% + 과당 50% 혼합물)을 탄소원으로 한 배지 중에서 배양하면서 대수기, 초기 정체기 및 정체기 단계별로 세포 추출물을 얻고, 이를 다음과 같은 조건으로 이차원 전기영동을 실시하여 단백질을 분리하였다. In this example, gene expression of coryneform bacteria was analyzed using proteomics techniques. During the log phase, initial stagnation, and stagnation phases, Corynebacterium ammonia genes wild (ATCC 6872) and CJHB100 (KCCM-10330) were incubated in a medium containing crude hydrolyzate (50% glucose + 50% fructose) as a carbon source. Cell extracts were obtained, and proteins were separated by two-dimensional electrophoresis under the following conditions.
먼저, 각각의 시료를 총 부피가 350 ㎕가 되도록 6M 우레아, 2M 티오우레아, 4% CHAPS, 0.4% DTT로 희석한 후, 7 ㎕의 IPG 버퍼, 3 ㎕의 1% 브로모페놀 블루 (BPB)를 가한 후 이들을 Immobiline pH gradient DrystripTM으로 재수화 트레이 위에서 시료를 얹고 시료의 증기화와 우레아의 결정화를 방지하기 위하여 2 ml의 커버 용액 (covering fluid)을 가하고, 대략 24시간 정도 실온에서 탈수시켰다. 이렇게 탈수가 완료된 겔을 0-100 V에서 1시간, 300 V에서 1시간, 600V에서 1시간, 그리고 대략 43-97 kVhr가 되도록 8000V의 시간을 조정하면서 (pH 4-7: 43.4 kVhr, pH 4.5-5.5, pH 5.5-6.7: 97 kVhr), 등전 포커싱 (isoelectric focusing)을 실시하 였다. 다음으로, 각각의 스트립을 20 mM Tris-HCl, pH 8.8, 6M 우레아, 2% SDS, 20% 글리세롤, 2.5 % 아크릴아미드 및 5 mM TBP에서 15분간 평형에 이르도록 하였다. 스트립의 평형이 완료된 후, 각각의 스트립을 2차원 겔 위에 얹고 0.5% 저 융점 아가로즈와 0.001% BPB가 들어있는 SDS로 봉합했으며, 약 19시간 동안 100 V로 전기영동을 실시하였다. First, each sample was diluted with 6M urea, 2M thiourea, 4% CHAPS, 0.4% DTT to a total volume of 350 μl, then 7 μl IPG buffer, 3 μl 1% bromophenol blue (BPB) After addition of these samples were placed on a rehydration tray with Immobiline pH gradient Drystrip ™ and 2 ml of covering fluid was added to prevent vaporization of the sample and crystallization of urea and dehydrated at room temperature for approximately 24 hours. The dehydrated gel was then conditioned at 8000 V for 1 hour at 0-100 V, 1 hour at 300 V, 1 hour at 600 V, and approximately 43-97 kVhr (pH 4-7: 43.4 kVhr, pH 4.5 -5.5, pH 5.5-6.7: 97 kVhr), isoelectric focusing was performed. Each strip was then equilibrated for 15 minutes in 20 mM Tris-HCl, pH 8.8, 6M urea, 2% SDS, 20% glycerol, 2.5% acrylamide and 5 mM TBP. After strip equilibration was complete, each strip was placed on a two-dimensional gel and sutured with SDS containing 0.5% low melting agarose and 0.001% BPB and subjected to electrophoresis at 100 V for about 19 hours.
전기영동 후 겔을 45% 메탄올, 5% 아세트산으로 고정시키고, 증류수로 1시간 동안 아세트산을 씻어냈다. 0.02% 소듐 티오설페이트로 2분간 감작화 (sensitization)시키고 증류수를 이용하여 1분씩 2번 세척하고, 겔을 0.1% 실버 나이트레이트와 20분간 반응시킨 다음 다시 증류수로 세척하였다. 이후 2% (w/v) 소듐 카르보네이트, 0.04% (v/v) 포름알데히드로 현상하여 원하는 세기의 단백질 스팟이 나타나면 1% 아세트산으로 반응을 정지시킨 후, 마지막으로 겔을 증류수로 세척하고, 밀봉된 플라스틱 백 속에 저장 후 4℃에서 보관하였다. 쿠마시 염색의 경우에는 겔을 꺼낸 후 30% 메탄올과 10% 아세트산으로 1시간 동안 고정하고 증류수로 간단히 씻은 후, 콜로이드성 쿠마시 브릴리어트 G250으로 24시간 동안 염색하였으며, 10% 메탄올과 7% 아세트산으로 4시간 동안 탈염색하였다. After electrophoresis, the gel was fixed with 45% methanol and 5% acetic acid, and the acetic acid was washed with distilled water for 1 hour. After sensitization with 0.02% sodium thiosulfate for 2 minutes and washing twice with distilled water for 1 minute, the gel was reacted with 0.1% silver nitrate for 20 minutes and then again with distilled water. After developing 2% (w / v) sodium carbonate and 0.04% (v / v) formaldehyde to stop the reaction with 1% acetic acid when a protein spot of the desired strength appears, the gel is washed with distilled water. After storage in a sealed plastic bag, it was stored at 4 ℃. In the case of Coomassie staining, the gel was taken out, fixed with 30% methanol and 10% acetic acid for 1 hour, washed briefly with distilled water, and then stained with colloidal Coomassie brilliance G250 for 24 hours, 10% methanol and 7% acetic acid. Destained for 4 hours.
전기 영동으로 분리된 단백질 스팟들로부터 펩티드를 추출하는 방법은 Shevchenko 등의 방법 (Shevchenko et al. Anal. Chem., 68(5), 850-8, 1996)을 변형하여 사용하였다. 단백질 스팟을 겔로부터 제거한 후, 120 ㎕의 30 mM 포타슘 페리시아나이드와 100mM 소듐 티오설페이트 1:1 혼합액에서 탈 염색한 후, 증류수로 15분씩 3번 세척 후 다시 120 ㎕의 50% 아세토니트릴/25 mM 암모늄 비카르보네이 트, pH 7.8로 10분간 세척하였다. 50 ㎕의 100% 아세토니트릴과 하얀색이 될 때까지 약 5분간 반응하고, 진공 건조기 Speed Vac를 이용하여 건조시켰다. Peptide extraction from protein spots isolated by electrophoresis was modified by Shevchenko et al. (Shevchenko et al. Anal. Chem., 68 (5), 850-8, 1996). Protein spots were removed from the gel, destained in 120 μl of 30 mM potassium ferricyanide and 100 mM sodium thiosulfate 1: 1 mixture, washed three times with distilled water three times for 15 minutes, and then 120 μl of 50% acetonitrile / 25. Washed with mM ammonium bicarbonate, pH 7.8 for 10 minutes. The reaction was carried out with 50 μl of 100% acetonitrile until it became white for about 5 minutes, and dried using a vacuum dryer Speed Vac.
질량 분석을 위한 단백질 스팟들을 겔로부터 얻은 후, 25 mM 암모늄 비카르보네이트, pH 7.8, 50% 아세토니트릴 용액으로 세척하고 색이 없어질 때까지 37℃에서 반응시켰다. 여기에 50 ㎕의 100% 아세토니트릴을 넣고 겔이 하얀 색으로 변할 때까지 약 5분간 반응하고 Speed Vac을 이용하여 건조시킨 후, 각 겔 마다 0.02μg/㎕ 트립신 10 ㎕를 가해 얼음 속에서 45분간 반응한 후, 다시 50 mM 암모늄 비카르보네이트 버퍼, pH 7.8을 가해 37℃에서 12-14 시간 반응시켰다. 그 후 펩티드의 추출을 원활하게 하기 위하여 10 ㎕ 0.5% TFA, 50% 아세토니트릴 속에서 10분간 3회 초음파 처리 방법으로 펩티드를 추출하였다. Protein spots for mass spectrometry were obtained from the gel, washed with 25 mM ammonium bicarbonate, pH 7.8, 50% acetonitrile solution and reacted at 37 ° C. until no color was obtained. Add 50 μl of 100% acetonitrile and react for about 5 minutes until the gel turns white, dry using Speed Vac, and add 10 μl of 0.02 μg / μl trypsin to each gel for 45 minutes in ice. After the reaction, 50 mM ammonium bicarbonate buffer, pH 7.8 was added thereto, and the reaction was carried out at 37 ° C for 12-14 hours. Then, the peptide was extracted by sonication three times for 10 minutes in 10 μl 0.5% TFA, 50% acetonitrile to facilitate the extraction of the peptide.
추출된 펩티드를 NSI MS/MS를 이용하여 다음과 같은 조건에서 분석하였다. HPLC 시스템은 Agilient 1100 시리즈를 사용하였으며, 나노 스프레이 이온화 소스가 장착된 Finnigan LCQ DECA 이온-트랩 질량 분석기 (ThermoQuest, San Jose, CA)와 연결하여 사용하였다. LC 상의 분리를 위하여 C18 마이크로프로브 역상 칼럼을 사용하였고, 용매 A는 0.1% 포름산, 용매 B는 90% (v/v) 아세토니트릴, 0.1% 수성 포름산으로 구성된 선형 구배 시스템 (유속 1㎕/min)을 사용해서, 다음과 같은 NSI 기준으로 측정하였다. 분무 전압, 1.8 kV; 모세관 온도, 200℃; 모세관 전압, 34 V; 튜브 렌즈 오프세트, 40 V; 전자, 증폭기는 -60V로 사용하였다. 모든 측정결과는 3회 측정 후 세트로이드 모드 (centroid mode)에서 수집되었으며 400-2000 Da의 완전한 MS 스캔을 얻은 후, 역치 값을 1 x 105 카운트로 고정하여 가장 강력한 이 온들을 고해상 줌 스캔으로 분리하고 다시 충돌-유도된 해리 (collision-induced dissociation) (CID) MS/MS를 실시하였다. 해석되지 않은 CID 스펙트럼들의 서열을 Thermo Finnigan 사의 제품인 TurboQuestTM 소프트웨어를 사용하여 확인하였다. SEQUEST 검색 결과는 교차 상관 (cross correlation)과 △Cn (델타 표준화된 상관)으로 확인하였다. 이러한 방법으로 분석된 펩티드의 아미노산 서열의 확인 및 동정은 Applied Biosystems사의 Q-star Pulsar LC MS/MS를 이용한 드 노보 서열 분석 (de novo sequencing)을, Applied Biosystems사에서 제공한 소프트웨어를 사용하여 실시하였다. The extracted peptides were analyzed using NSI MS / MS under the following conditions. The HPLC system used an Agilient 1100 series and was used in conjunction with a Finnigan LCQ DECA ion-trap mass spectrometer (ThermoQuest, San Jose, Calif.) Equipped with a nano spray ionization source. A C18 microprobe reversed phase column was used for separation on the LC phase, and a linear gradient system consisting of 0.1% formic acid with solvent A, 90% (v / v) acetonitrile, 0.1% aqueous formic acid (flow rate 1 μl / min) Using was measured based on the following NSI standards. Spray voltage, 1.8 kV; Capillary temperature, 200 ° C .; Capillary voltage, 34 V; Tube lens offset, 40 V; The former and the amplifier were used at -60V. All measurements were collected in setroid mode after three measurements and after a full MS scan of 400-2000 Da, the threshold values were fixed at 1 x 105 counts to isolate the most powerful ions into a high resolution zoom scan. Then again collision-induced dissociation (CID) MS / MS was performed. Sequences of uninterpreted CID spectra were identified using TurboQuest ™ software from Thermo Finnigan. SEQUEST search results were confirmed by cross correlation and ΔCn (delta standardized correlation). Identification and identification of amino acid sequences of peptides analyzed in this manner were carried out using de novo sequencing using Applied Biosystems' Q-star Pulsar LC MS / MS using software provided by Applied Biosystems. .
이상의 방법으로 선별된 과발현 단백질의 유전정보를 염색체 서열정보 (NCBI: http://www.ncbi.nlm.nih.gov/)를 바탕으로 분석하여 푸마레이즈를 선별하였다. 도 1은 프로테옴 분석에 의하여 코리네박테리움 암모니아게네스 야생주 (ATCC 6872)와 코리네박테리움 암모니아게네스 CJHB100 (KCCM-10330)의 푸마레이즈의 발현 분석 결과를 나타내는 도면이다. 도 1에서 A와 B는 각각 코리네박테리움 암모니아게네스 야생주 (ATCC 6872)와 코리네박테리움 암모니아게네스 CJHB100 (KCCM-10330)의 푸마레이즈의 발현을 나타낸다. Genetic information of the overexpressed protein selected by the above method was analyzed based on chromosome sequence information (NCBI: http://www.ncbi.nlm.nih.gov/) to select fumarases. 1 is a graph showing the results of the analysis of the fumarase expression of Corynebacterium ammonia genes wild strain (ATCC 6872) and Corynebacterium ammonia genes CJHB100 (KCCM-10330) by proteome analysis. In Figure 1, A and B show the expression of fumarase of Corynebacterium ammonia genes wild strain (ATCC 6872) and Corynebacterium ammonia genes CJHB100 (KCCM-10330), respectively.
실시예Example 2: 2: 푸마레이즈Puma Raise 유전자 서열을 함유하는 재조합 벡터 Recombinant vector containing gene sequence p117p117 -FUM 제작-FUM production
Eikmann 등 (Gene, 102, 93-98, 1991)의 방법에 따라, 1 일간 배양한 코리네박테리움 암모니아게네스 야생주 (ATCC 6872) 25 ㎖로부터 염색체 DNA 500 ㎍을 분리하였다. 분리된 염색체를 주형으로 서열번호 1과 2의 올리고뉴클레오티드를 프라이 머로 사용한 PCR을 통하여 과발현 단백질인 푸마레이즈 유전자를 증폭하였다. PCR은 94 ℃에서 30 초, 55 ℃에서 30 초, 72 ℃에서 30 초간의 반응 사이클을 30 회 반복하였다. According to the method of Eikmann et al. (Gene, 102, 93-98, 1991), 500 µg of chromosomal DNA was isolated from 25 ml of Corynebacterium ammonia genes (ATCC 6872) cultured for 1 day. Oligonucleotides of SEQ ID NOs: 1 and 2 were used as templates for the isolated chromosomes. The fumarase gene, an overexpressed protein, was amplified by PCR used as a primer. PCR was repeated 30 times of reaction cycles for 30 seconds at 94 ℃, 30 seconds at 55 ℃, 30 seconds at 72 ℃.
증폭된 유전자를 BamHI과 EcoRV로 절단하여 대장균과 코리네형 세균에서 발현 가능한 셔틀벡터인 pECCG117 (KFCC-10673/KFCC-10674)의 BamHI과 EcoRV 위치에 도입한 후, T4 리가제 10 유니트를 이용하여 16 ℃에서 16 시간 동안 결찰 반응을 수행하였다. 이렇게 얻은 재조합 벡터 (p117-FUM)를 van der Rest 등의 방법 (Appl. Microbiol. Biotechnol., 52, 541-545, 1999)으로 형질전환이 가능하게 만든 코리네박테리움 암모니아게네스 CJHB100 (KCCM-10330)에 도입시켰다. 형질전환된 균주를 카나마이신 10 ㎍/㎖이 포함된 CM 배지 (펩톤 1%, 육즙 1%, 염화나트륨 0.25%, 효모 추출물 1%, 아데닌 100mg/ml, 구아닌 100mg/ml, 한천 2% (pH 7.2))에 도말하여 32 ℃에서 3 일간 배양하면서 성장하는 균주를 선별하고, 선별된 코리네박테리움 암모니아게네스 CJFUM101 (KCCM-10689P)로 명명하였다.The introduction of the amplified genes in the Bam HI and Eco RV location of the Bam HI and Eco cut to RV expressed in E. coli and coryneform bacteria can shuttle vector of pECCG117 (KFCC-10673 / KFCC- 10674) and then, T4 ligase 10 units The ligation reaction was carried out at 16 ° C. for 16 hours. The recombinant vector (p117-FUM) thus obtained was transformed by the method of van der Rest et al. (Appl. Microbiol. Biotechnol., 52, 541-545, 1999). Corynebacterium ammonia genes CJHB100 (KCCM- 10330). Transformed strains were CM medium containing 10 μg / ml of kanamycin (1% peptone, 1% broth, 0.25% sodium chloride, 1% yeast extract, 100 mg / ml adenine, 100 mg / ml guanine, 2% agar (pH 7.2)). ), Strains grown during 3 days of culture at 32 ° C. were selected and named as the selected Corynebacterium ammonia genes CJFUM101 (KCCM-10689P).
실시예Example 3: 삼각플라스크 발효실험 3: Erlenmeyer flask fermentation experiment
실시예 2에서 얻어진 코리네박테리움 암모니아게네스 CJFUM101 (KCCM-10689P)를 배양하고, 세포 성장 및 5'-이노신산의 생산량을 측정하였다. Corynebacterium ammonia gene CJFUM101 (KCCM-10689P) obtained in Example 2 was cultured, and cell growth and yield of 5'-inosinic acid were measured.
표 1에 나타낸 바와 같은 종 배지 3ml를 지름 18mm 시험관에 분주하고 통상의 방법에 따라 가압 살균한 후 코리네박테리움 암모니아게네스 CJFUM101 (KCCM-10689P) 균주를 접종하고 30℃ 온도에서 24시간 진탕 배양하고, 얻어진 배양액을 종 배양액으로 사용하였다. Dispense 3 ml of the seed medium as shown in Table 1 into a 18 mm diameter test tube, autoclave sterilization according to a conventional method, inoculate the strain of Corynebacterium ammonia genes CJFUM101 (KCCM-10689P), and incubate shaking at 30 ° C. for 24 hours. And the obtained culture liquid was used as a seed culture liquid.
표 1에 나타낸 바와 같은 발효 배지 27ml를 500ml 진탕용 삼각플라스크에 분주하고 120℃ 온도에서 10분간 가압 살균한 다음, 상기한 얻어진 종 배양액 3ml를 접종한 다음 5일 동안 배양하였다. 배양하는 동안 플라스크의 회전수는 분당 200회, 온도는 32℃, pH는 pH 7.2로 조절하였다. 배양 중 지정된 시간에 세포 성장 및 5'-이노신산의 양을 각각 스펙트로포토미터의 흡광도와 고성능 액체 크로마토그래피(High performance liquid chromatography)로 측정하였으며, 그 결과는 표 2와 같다. 27 ml of fermentation medium as shown in Table 1 was dispensed into a 500 ml shake flask for 10 minutes, sterilized under pressure at 120 ° C. for 10 minutes, and then inoculated with 3 ml of the obtained seed culture, followed by incubation for 5 days. During the incubation, the rotation speed of the flask was adjusted to 200 times per minute, the temperature to 32 ° C., and the pH to pH 7.2. Cell growth and the amount of 5'-inosinic acid at the designated time during incubation were measured by spectrophotometer absorbance and high performance liquid chromatography, respectively, and the results are shown in Table 2 below.
표 2.Table 2.
표 2에 나타낸 바와 같이, 코리네박테리움 암모니아게네스 CJFUM101 (KCCM-10689P)는 모균주인 CJHB100 (KCCM-10330)에 비하여, 배양 3일 경과 후에는 세포성장 및 5'-이노신산의 생성성이 우수하였으며 배양 최종 시점인 5일 후에는 거의 동일하였다. 이는 코리네박테리움 암모니아게네스 CJFUM101 (KCCM-10689P) 균주가 동일한 조건하에서 균체의 성장속도가 우수하고, 그에 따라 단위 시간당의 5'-이노신산의 생산성이 더 우수하다는 것을 나타낸다. As shown in Table 2, Corynebacterium ammonia genes CJFUM101 (KCCM-10689P), compared to the parent strain CJHB100 (KCCM-10330), after three days of culture cell growth and production of 5'-inosinic acid Excellent and almost identical after 5 days of culture. This indicates that the Corynebacterium ammonia genes CJFUM101 (KCCM-10689P) strain had a good growth rate of the cells under the same conditions, and thus a higher productivity of 5'-inosinic acid per unit time.
실시예Example 4: 1리터 발효조에서의 실험 4: Experiment in 1 liter fermenter
실시예 2에서 얻어진 코리네박테리움 암모니아게네스 CJFUM101 (KCCM-10689P)를 1리터 발효조에서 배양하고, 세포 성장 및 5'-이노신산의 생산량을 측정 하였다. Corynebacterium ammonia gene CJFUM101 (KCCM-10689P) obtained in Example 2 was cultured in a 1 liter fermenter, and cell growth and 5'-inosinic acid production were measured.
표 1에 나타낸 바와 같은 종 배지 50ml를 500ml 진탕용 삼각플라스크에 분주하고 통상의 방법에 따라 가압 살균한 다음, 코리네박테리움 암모니아게네스 CJFUM101 (KCCM-10689P) 균주를 접종하고 30℃에서 24시간 동안 진탕 배양하고, 얻어진 배양액을 사용하였다. 50 ml of the seed medium as shown in Table 1 were dispensed into a 500 ml shake flask, autoclaved according to a conventional method, inoculated with the strain of Corynebacterium ammonia genes CJFUM101 (KCCM-10689P) and incubated at 30 ° C for 24 hours. While shaking culture, and the obtained culture was used.
또한, 표 1에 나타낸 바와 같은 발효조 본 배지 1000ml를 1L-발효조에 넣고 온도 120℃에서 15분간 가압 살균하여, 상기한 발효조 종 배양액 50ml를 접종한 다음, 3일 동안 배양하였다. 배양하는 동안 임펠러 회전수는 분당 900회, 온도 30℃, pH 7.2으로 조절하였다. 배양 후 세포 성장 및 5'-이노신산의 양을 측정하였다. 그 결과를 표 3에 나타내었다. In addition, the fermenter as shown in Table 1 1000ml of this medium in a 1L-fermentation tank and autoclaved for 15 minutes at a temperature of 120 ℃, inoculated with 50ml of the above fermenter broth culture medium, and then cultured for 3 days. The impeller rotation rate was adjusted to 900 times per minute, temperature 30 ° C., and pH 7.2 during the culture. After incubation the cell growth and the amount of 5'-inosinic acid were measured. The results are shown in Table 3.
표 3. 1리터 발효조 발효 결과Table 3. 1 liter fermenter fermentation results
표 3에 나타낸 바와 같이, 푸마레이즈 유전자를 과발현하는 코리네박테리움 암모니아게네스 CJFUM101 (KCCM-10689P) 균주가 모균주인 CJHB100 (KCCM-10330)에 비하여 세포 성장이 우수하고, 단축된 발효 시간에 높은 5'-이노신산 생산성을 발취하였다. As shown in Table 3, the Corynebacterium ammonia gene CJFUM101 (KCCM-10689P) strain overexpressing the fumarase gene showed better cell growth and shorter fermentation time than the parent strain CJHB100 (KCCM-10330). High 5'-inosinic acid productivity was extracted.
본 발명의 균주에 따르면, 모균주에 비하여 증가된 발현량의 푸마레이즈 유전자를 갖는 코리네박테리움 속 미생물은, 5'-이노신산의 생산성은 높으면서도 세포 성장 속도가 빨라 5'-이노신산을 효율적으로 생산하는 데 사용할 수 있다.According to the strain of the present invention, the microorganism of the genus Corynebacterium having an increased expression amount of the fumarase gene compared to the parent strain, has high productivity of 5'-inosinic acid and has high cell growth rate, thus efficiently producing 5'-inosinic acid. Can be used to produce
본 발명의 방법에 따르면, 발효시간을 단축함으로써 5'-이노신산을 효율적으로 생산할 수 있다. According to the method of the present invention, 5'-inosinic acid can be efficiently produced by shortening the fermentation time.
<110> CJ Corporation <120> A microorganism of Corynebacterium genus comprising an enhanced expression of fumarase gene producing 5'-inosinic acid in high productivity and a method of producing 5'-inosinic acid using the same <130> PN065312 <160> 2 <170> KopatentIn 1.71 <210> 1 <211> 18 <212> DNA <213> Artificial Sequence <220> <223> A primer for fumarase gene amplification <400> 1 gtaattgact actccgac 18 <210> 2 <211> 33 <212> DNA <213> Artificial Sequence <220> <223> A primer for fumarase gene amplification <400> 2 cgcggatcca gcgtcctggc gaggcgactg att 33 <110> CJ Corporation <120> A microorganism of Corynebacterium genus comprising an enhanced expression of fumarase gene producing 5'-inosinic acid in high productivity and a method of producing 5'-inosinic acid using the same <130> PN065312 <160> 2 <170> KopatentIn 1.71 <210> 1 <211> 18 <212> DNA <213> Artificial Sequence <220> A primer for fumarase gene amplification <400> 1 gtaattgact actccgac 18 <210> 2 <211> 33 <212> DNA <213> Artificial Sequence <220> A primer for fumarase gene amplification <400> 2 cgcggatcca gcgtcctggc gaggcgactg att 33
Claims (8)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020050119250A KR20070060208A (en) | 2005-12-08 | 2005-12-08 | Corynebacterium microorganisms having excellent 5'-inosine acid productivity with increased fumarase gene expression and a method for producing 5'-inosine acid using the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020050119250A KR20070060208A (en) | 2005-12-08 | 2005-12-08 | Corynebacterium microorganisms having excellent 5'-inosine acid productivity with increased fumarase gene expression and a method for producing 5'-inosine acid using the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20070060208A true KR20070060208A (en) | 2007-06-13 |
Family
ID=38356251
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020050119250A Withdrawn KR20070060208A (en) | 2005-12-08 | 2005-12-08 | Corynebacterium microorganisms having excellent 5'-inosine acid productivity with increased fumarase gene expression and a method for producing 5'-inosine acid using the same |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR20070060208A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019117399A1 (en) * | 2017-12-15 | 2019-06-20 | 씨제이제일제당 (주) | Novel polypeptide and imp production method using same |
| WO2019135445A1 (en) * | 2018-01-04 | 2019-07-11 | 씨제이제일제당 (주) | Novel polypeptide and method for producing imp by using same |
| US11155849B2 (en) | 2017-12-15 | 2021-10-26 | Cj Cheiljedang Corporation | IMP-producing microorganism and method of producing IMP using the same |
| US11180754B2 (en) | 2017-12-15 | 2021-11-23 | Cj Cheiljedang Corporation | Polypeptide and method of producing IMP using the same |
-
2005
- 2005-12-08 KR KR1020050119250A patent/KR20070060208A/en not_active Withdrawn
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019117399A1 (en) * | 2017-12-15 | 2019-06-20 | 씨제이제일제당 (주) | Novel polypeptide and imp production method using same |
| US11155849B2 (en) | 2017-12-15 | 2021-10-26 | Cj Cheiljedang Corporation | IMP-producing microorganism and method of producing IMP using the same |
| US11180754B2 (en) | 2017-12-15 | 2021-11-23 | Cj Cheiljedang Corporation | Polypeptide and method of producing IMP using the same |
| US11299521B2 (en) | 2017-12-15 | 2022-04-12 | Cj Cheiljedang Corporation | Polypeptide and method of producing IMP using the same |
| US11584786B2 (en) | 2017-12-15 | 2023-02-21 | Cj Cheiljedang Corporation | Polypeptide and method of producing IMP using the same |
| US11987611B2 (en) | 2017-12-15 | 2024-05-21 | Cj Cheiljedang Corporation | Polypeptide and method of producing IMP using the same |
| WO2019135445A1 (en) * | 2018-01-04 | 2019-07-11 | 씨제이제일제당 (주) | Novel polypeptide and method for producing imp by using same |
| US11384124B2 (en) | 2018-01-04 | 2022-07-12 | Cj Cheiljedang Corporation | Polypeptide and method of producing IMP using the same |
| US11746130B2 (en) | 2018-01-04 | 2023-09-05 | Cj Cheiljedang Corporation | Polypeptide and method of producing IMP using the same |
| US12269851B2 (en) | 2018-01-04 | 2025-04-08 | Cj Cheiljedang Corporation | Polypeptide and method of producing IMP using the same |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102013873B1 (en) | A microorganism of the genus Corynebacterium producing purine nucleotide and method for producing purine nucleotide using the same | |
| EP2415861B1 (en) | Microorganisms of corynebacterium with improved 5'-inosinic acid productivity, and method for producing nucleic acids using same | |
| US7160705B2 (en) | Arginine repressor deficient strain of coryneform bacterium and method for producing L-arginine | |
| WO1997008294A1 (en) | Process for producing l-glutamic acid by fermentation method | |
| JP2011019524A (en) | Promoter nucleic acid originated from bacteria of genus corynebacterium, expression cassette containing promoter, vector containing cassette, host cell containing vector and method for expressing gene by using the same | |
| JP5857973B2 (en) | Yeast extract containing γ-Glu-X or γ-Glu-X-Gly and method for producing the same | |
| Petersen et al. | Identification and characterization of an operon in Salmonella typhimurium involved in thiamine biosynthesis | |
| KR100830289B1 (en) | L-arginine production mutant strain and preparation method thereof | |
| EP4424834A2 (en) | Microorganism having increased activity of 3-methyl-2-oxobutanoate hydroxymethyltransferase, and use thereof | |
| KR20220152728A (en) | Microorganism having inhanced activity of 3-methyl-2-oxobutanoate hydroxymethyltransferase and uses thereof | |
| JPWO1997000944A1 (en) | Transformant producing PF1022 substance and method for transforming fungi belonging to the class of filamentous fungi | |
| AU784466B2 (en) | Cyclic depsipeptide synthases, genes thereof and mass production system of cyclic depsipeptide | |
| KR20070060208A (en) | Corynebacterium microorganisms having excellent 5'-inosine acid productivity with increased fumarase gene expression and a method for producing 5'-inosine acid using the same | |
| KR20070060207A (en) | 5'-inosinic acid microorganism having high productivity of increased lipoamide dehydrogenase gene expression and a method of producing 5'-inosine acid using the same | |
| KR102433234B1 (en) | Mutant of Corynebacterium glutamicum with enhanced L-citrulline productivity and method for preparing L-citrulline using the same | |
| JPH06225776A (en) | Riboflavin production method | |
| KR100768750B1 (en) | 5'-inosinic acid-producing microorganisms having enhanced biotin carboxylase activity and a method of producing 5'-inosine acid using the same | |
| KR20070060206A (en) | 5'-inosinic acid microorganisms having excellent productivity of 5'-inosinic acid with increased expression of glyceraldehyde-3-phosphate dehydrogenase gene and a method for producing 5'-inosine acid using the same | |
| KR101056872B1 (en) | Microorganisms in Corynebacterium with Improved Productivity of Nucleic Acid-Based Materials and Methods for Producing Nucleic Acid-Based Materials Using the Same | |
| CN114181288B (en) | Method for preparing L-valine and gene used therefor and protein encoded by the gene | |
| EP4644555A1 (en) | Galactose-1-phosphate uridyltransferase mutant and use thereof in preparation of l-lysine | |
| KR100857379B1 (en) | Microorganisms Overexpressing Phosphoribosyl Aminoimidazole Carboxylase and Method for Production of 5'-inosine Acid Using the Same | |
| US8039434B2 (en) | Method for producing human insulin-like growth factor I | |
| EP4424821A1 (en) | Enzymatic synthesis of odilorhabdin and related peptides/proteins comprising non-standard amino acid residues | |
| KR20080006799A (en) | Method for producing L-arginine using gene arcGF sequences with improved titer and transgenic strains comprising the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20051208 |
|
| PG1501 | Laying open of application | ||
| N231 | Notification of change of applicant | ||
| PN2301 | Change of applicant |
Patent event date: 20080111 Comment text: Notification of Change of Applicant Patent event code: PN23011R01D |
|
| PC1203 | Withdrawal of no request for examination | ||
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |